Novo Nordisk to end semaglutide kidney study early due to strong efficacy signalsNovo Nordisk is ending its Phase III FLOW trial ahead of schedule after an interim analysis of the kidney outcomes study of semaglutide...
Why obesity leads to a complex inflammatory response inside adipose tissueA study by Dr Lindsey Muir, a research assistant professor in the Department of Computational Medicine and Bioinformatics, and colleagues...
Allurion completes AUDACITY trial enrolment for Allurion BalloonAllurion Technologies has completed patient enrolment in its AUDACITY trial, a randomised, pivotal controlled trial designed to support...
Journal Watch 11/10/2023Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
GLP-1 coverage in employer plans could double in 2024Findings from a recent employer survey on sentiment and adoption of GLP-1 medications by Accolade and Savanta on sentiment and adoption...
Bariatric surgery cures urinary incontinence in one of three womenBariatric surgery is able to cure urinary incontinence in one of three women with obesity and a significant improvement was obtained in...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment4 days ago